Feedback
AUROPHARMA 
Reputation: 642,681 • Jul 24, 2023 3:43 PM
Aurobindo Pharma gets 3 observations from USFDA, stock rebounds from early losses
The observations are procedural in nature and we will respond to the USFDA within the stipulated timelines, company said in its release.
Moneycontrol
Vote
Comment
Share
NSE:AUROPHARMA price when posted: 785.55